CAS 1253491-42-7

Fórmula: C22H16N2O

InChI: InChI=1S/C22H16N2O/c1-25-15-9-10-20-19(13-15)18-11-12-23-21(22(18)24-20)17-8-4-6-14-5-2-3-7-16(14)17/h2-13,24H,1H3

Clave InChI: AABFWJDLCCDJJN-UHFFFAOYSA-N

SMILES: COC1=CC2=C(C=C1)NC3=C2C=CN=C3C4=CC=CC5=CC=CC=C54

SP-141

CAS: 1253491-42-7

SP-141

Fórmula: C₂₂H₁₆N₂O

Pureza: ≥98%

Peso molecular: 324.38

Ref: 54-BUP02569

SP 141

CAS: 1253491-42-7

Fórmula: C₂₂H₁₆N₂O

Pureza: 98%

Forma y color: Solid

Peso molecular: 324.3752

Ref: IN-DA01E0NC

SP-141

CAS: 1253491-42-7

SP 141 is a MDM2 inhibitor.SP-141 promotes MDM2 auto-ubiquitination and degradation, with anticancer activity.

Fórmula: C₂₂H₁₆N₂O

Pureza: 98.01%

Forma y color: Solid

Peso molecular: 324.38

Ref: TM-T21773

SP-141

CAS: 1253491-42-7

6-Methoxy-1-(naphthalen-1-yl)-9H-pyrido[3,4-b]indole

Fórmula: C₂₂H₁₆N₂O

Pureza: 98%

Peso molecular: 324.38

Ref: IN-DG00797630

SP 141

Producto controlado

CAS: 1253491-42-7

Fórmula: C₂₂H₁₆N₂O

Forma y color: Neat

Peso molecular: 324.38

Ref: TR-S678500

SP 141

CAS: 1253491-42-7

SP141 is a monoclonal antibody that specifically binds to β-catenin, which is an essential component of the Wnt signaling pathway. SP141 inhibits the transcriptional activity of β-catenin, leading to reduced cell proliferation and tumor growth in CD1 mice. SP141 has been shown to induce apoptosis in various cancer cells and synergize with other types of monoclonal antibodies. SP141 was also found to be effective at reducing tumor size in human carcinoma cell lines and clinical pathology specimens.

Fórmula: C₂₂H₁₆N₂O

Pureza: Min. 95%

Peso molecular: 324.38 g/mol

Ref: 3D-DAC49142